Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer
Dokmanovic, M., Hirsch, D. S., Shen, Y., Wu, W. J.Volume:
8
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.mct-09-0140
Date:
June, 2009
File:
PDF, 948 KB
english, 2009